Failure of Dupilimab with Severe Prurigo Nodularis That Responded Well to Abrocitinib
Ashley Vander Does, Gil Yosipovitch
Topics & Concepts
MiamiPrurigo nodularisMedicineConceptualizationDermatologyPrurigoComputer scienceEnvironmental scienceArtificial intelligenceSoil scienceDermatology and Skin DiseasesAutoimmune Bullous Skin DiseasesCutaneous lymphoproliferative disorders research